RGNX

RGNX

USD

REGENXBIO Inc. Common Stock

$11.560+0.140 (1.226%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$11.420

High

$11.955

Low

$11.375

Volume

0.20M

Company Fundamentals

Market Cap

583.9M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.60M

Exchange

NMS

Currency

USD

52-Week Range

Low $5.035Current $11.560High $13.925

Related News

PR Newswire

REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program

REGENXBIO Inc. (Nasdaq: RGNX) today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational...

View more
REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
PR Newswire

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial...

View more
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
PR Newswire

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan's 9th Annual Genetic Medicines...

View more
REGENXBIO to Participate in Upcoming Investor Conferences